| 1 |
陈茹，郑荣寿，张思维，等．2015年中国食管癌发病和死亡情况分析[J]．中华预防医学杂志，2019，53(11)：1094-1097．
|
| 2 |
GBD 2017 Oesophageal Cancer Collaborators. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Gastroenterol Hepatol, 2020, 5(6): 582-597.
|
| 3 |
Editorial Office. New perspectives in multidisciplinary treatment of esophageal cancer: the "First East Asian Conference on Multidisciplinary Treatment of Esophageal Cancer" held in Chengdu, Sichuan Province[J]. J Thorac Dis, 2018, 10(5): E400-E408.
|
| 4 |
Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach[J]. J R Coll Surg Edinb, 1992, 37(1): 7-11.
|
| 5 |
Osugi H, Takemura M, Higashino M, et al. A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation[J]. Br J Surg, 2003, 90(1): 108-113.
|
| 6 |
Daiko H, Nishimura M. A pilot study of the technical and oncologic feasibility of thoracoscopic esophagectomy with extended lymph node dissection in the prone position for clinical stage I thoracic esophageal carcinoma[J]. Surg Endosc, 2012, 26(3): 673-680.
|
| 7 |
Fujiwara H, Kanamori J, Nakajima Y, et al. An anatomical hypothesis: a "concentric-structured model" for the theoretical understanding of the surgical anatomy in the upper mediastinum required for esophagectomy with radical mediastinal lymph node dissection[J]. Dis Esophagus, 2019, 32(8): doy119.
|
| 8 |
Fujiwara H, Shiozaki A, Konishi H, et al. Single-Port Mediastinoscopic Lymphadenectomy Along the Left Recurrent Laryngeal Nerve[J]. Ann Thorac Surg, 2015, 100(3): 1115-1117.
|
| 9 |
Daiko H, Oguma J, Fujiwara H, et al. Novel universally applicable technique for performing bilateral transcervical mediastinoscopic-assisted transhiatal laparoscopic esophagectomy: a truly minimally invasive procedure[J]. Surg Endosc, 2020. [Epub ahead of print].
|
| 10 |
Daiko H, Fujita T, Ohgara T, et al. Minimally invasive hybrid surgery combined with endoscopic and thoracoscopic approaches for submucosal tumor originating from thoracic esophagus[J]. World J Surg Oncol, 2015, 13: 40.
|
| 11 |
Kanamori J, Abe S, Kurita D, et al. Minimally invasive hybrid surgery: A salvage tumor enucleation for local recurrence of thoracic esophageal carcinoma after definitive chemoradiotherapy[J]. Asian J Endosc Surg, 2021, 14(1): 77-80.
|
| 12 |
Miyamoto S, Sakuraba M, Asano T, et al. Free jejunal patch graft for reconstruction after partial hypopharyngectomy with laryngeal preservation[J]. Arch Otolaryngol Head Neck Surg, 2011, 137(2): 181-186.
|
| 13 |
Daiko H, Fujita T, Oguma J, et al. Novel minimally invasive approach to lymph node dissection around the left renal vein in patients with esophagogastric junction cancer[J]. Esophagus, 2020. [Epub ahead of print].
|
| 14 |
Daiko H, Oguma J, Fujiwara H, et al. Robotic esophagectomy with total mediastinal lymphadenectomy using four robotic arms alone in esophageal and esophagogastric cancer (RETML-4): a prospective feasibility study[J]. Esophagus, 2020. [Epub ahead of print].
|
| 15 |
Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus[J]. Ann Surg, 1994, 220(3): 364-372.
|
| 16 |
Tachimori Y, Kato H, Watanabe H, et al. Neck ultrasonography for thoracic esophageal carcinoma[J]. Ann Thorac Surg, 1994, 57(5): 1180-1183.
|
| 17 |
Tachimori Y, Nagai Y, Kanamori N, et al. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system[J]. Dis Esophagus, 2011, 24(1): 33-38.
|
| 18 |
Tachimori Y, Ozawa S, Numasaki H, et al. Supraclavicular node metastasis from thoracic esophageal carcinoma: A surgical series from a Japanese multi-institutional nationwide registry of esophageal cancer[J]. J Thorac Cardiovasc Surg, 2014, 148(4): 1224-1229.
|
| 19 |
Sakaki A, Kanamori J, Ishiyama K, et al. Distribution of lymph node metastases in locally advanced adenocarcinomas of the esophagogastric junction (cT2-4): comparison between Siewert type I and selected Siewert type II tumors[J]. Langenbecks Arch Surg, 2020, 405(4): 509-519.
|
| 20 |
Kurokawa Y, Takeuchi H, Doki Y, et al. Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study[J]. Ann Surg, 2019. [Epub ahead of print].
|
| 21 |
Higashi T, Nakamura F, Saruki N, et al. Establishing a quality measurement system for cancer care in Japan[J]. Jpn J Clin Oncol, 2013, 43(3): 225-232.
|
| 22 |
Nakamura K, Kato K, Igaki H, et al. Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study)[J]. Jpn J Clin Oncol, 2013, 43(7): 752-755.
|
| 23 |
Hara H, Tahara M, Daiko H, et al. Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma[J]. Cancer Sci, 2013, 104(11): 1455-1460.
|
| 24 |
Nozaki I, Kato K, Igaki H, et al. Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study[J]. Surg Endosc, 2015, 29(12): 3519-3526.
|
| 25 |
Kataoka K, Takeuchi H, Mizusawa J, et al. A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409[J]. Jpn J Clin Oncol, 2016, 46(2): 174-177.
|
| 26 |
Zenda S, Kojima T, Kato K, et al. Multicenter Phase 2 Study of Cisplatin and 5-Fluorouracil With Concurrent Radiation Therapy as an Organ Preservation Approach in Patients With Squamous Cell Carcinoma of the Cervical Esophagus[J]. Int J Radiat Oncol Biol Phys, 2016, 96(5): 976-984.
|
| 27 |
Terada M, Hara H, Daiko H, et al. Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE)[J]. Jpn J Clin Oncol, 2019, 49(11): 1055-1060.
|
| 28 |
Hashimoto J, Kato K, Ito Y, et al. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma[J]. Int J Clin Oncol, 2019, 24(1): 60-67.
|
| 29 |
Yamamoto S, Kato K, Daiko H, et al. Feasibility study of nivolumab as neoadjuvant chemotherapy for locally esophageal carcinoma: FRONTiER (JCOG1804E)[J]. Future Oncol, 2020, 16(19): 1351-1357.
|
| 30 |
Daiko H, Marafioti T, Fujiwara T, et al. Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients[J]. Cancer Immunol Immunother, 2020, 69(11): 2247-2257.
|
| 31 |
冷雪峰，郭旭峰，大幸宏幸．第74回日本消化器外科学会总会食管癌治疗内容拔萃[J]．中国胸心血管外科临床杂志，2019，26(10)：11-15．
|
| 32 |
郭旭峰，冷雪峰，戴亮．食管癌外科热点问题——日本专家访谈[J]．中华胸部外科电子杂志，2019，6(4)：207-211．
|